|
|
 |
Olivier Cochet, Ph.D
Director of Industrial Biotechnology
Centre d'Immunologie Pierre Fabre, France
Olivier Cochet holds a PhD in Pharmacology, with a specialization in immunology. During his academic career at the MRC ( Cambridge , UK ), at INSERM and at the Institut Curie ( Paris , France ), he worked on technologies to generate recombinant monoclonal antibodies.
He then worked as the Bioinformatics and Biotechnology Director at ExonHit Therapeutics (Paris) for 7 years where he was in charge of designing DNA microarrays for the identification of diseases linked to changes in alternative splicing mechanisms.
Olivier Cochet joined the Pierre-Fabre group in 2005 as Director of Industrial Biotechnology, with responsibility for the development and clinical-grade production of biologics. |
|
|
|
|
 |
|
 |
David Wood, PhD
Assistant Professor, Department of Chemical Engineering
Princeton University
David Wood is an assistant professor of Chemical Engineering at Princeton University working in the areas of protein engineering, bioseparations and biosensing. He completed a double major in Chemical Engineering and Molecular Biology from Caltech in 1990, and then worked one year at Kelco in commodity-scale bioprocess development, followed by two years at Amgen in Neupogen® manufacturing.
During his PhD work he was co-advised by Georges Belfort (a chemical engineer specializing in bioseparations) and Marlene Belfort (a molecular geneticist working with mobile genetic elements). This work led to the generation of an engineered, evolved self-cleaving protein element (intein) for applications in recombinant protein purification.
At Princeton, he has combined this self-cleaving element with two novel self-cleaving purification tags to create new non-chromatographic separation technologies. These technologies have been requested by over 100 laboratories worldwide. His current focus is on the development of these systems for industrially relevant protein targets and processes. |
|
| |
|
|
|
|
 |
George O Lovrecz
Project Leader, Molecular and Health Technologies
CSIRO, Australia
Dr George Lovrecz is a Principal Research Scientist at CSIRO Molecular and Health Technologies with close to 30 years experience in fermentation, specialising in the scale-up of mammal ian cell cultures. His early projects involved the development of an on-line computer-linked control for bioreactors using novel techniques and the scale-up and GMP production of human growth hormone (hGH) at the University of New South Wales in conjunction with CSL and the Garvan Institute.
Later he become responsible for the operation of the Recombinant Products Laboratories at the University of New South Wales ( Sydney ) and gave lectures: Bioengineering Principles. He joined CSIRO (Melbourne) in 1995 as the head of the Fermentation Group, where he provides expertise in the area of large-scale production, optimisation, development and characterisation of recombinant proteins for internal and external research collaborators. He had an integral role in the development of a various platform technologies to produce mammalian and insect cell receptor glycoproteins.
The resulting achievements of this work included the 3D structure of hIR and EGF receptors fragments the first published instance from this receptor family. At present George is coordinating the building and establishment of a new pilot-scale fermentation facility as part of National Collaborative Research Infrastructure Strategy (NCRIS) initiative. George is still involved in regular training and teaching: Bioprocessing Technology and Tissue Culture at various institutes. |
|
|
|
|
| |
|
READ MORE 
Future Technologies In Biologics Manufacturing -Transform Bioprocess Productivity And Over Come The Challenges Of Speed, Survival And Innovation
